Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolmitriptan in Primary Care Migraine Management
NCT00637286Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2004
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of zolmitriptan in migraine, sponsored by AstraZeneca. Primary endpoint: Migraine Disability Assessment at 28 weeks. Started Jul 2004; status: completed.
02
Drugs
zolmitriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00637286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637286.